VERISANTE TECHNOLOGY Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VERISANTE TECHNOLOGY

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dalroi who wrote (23)	11/13/2011 8:32:24 PM
From: Mark Bartlett	of 254

Stefaan, According to their site, from an "n" of ~ 1000 lesions examined, 274 suspect skin lesion were sent for biopsy. The machine correctly found all (34) of the true positives (as determined by biopsy) for melanoma (the most serious form of skin cancer). I do not believe there were any false postives. You ask excellent questions re false positives, but Health Canada would be asking the exact same questions as part of their review. When Health Canada reviews the data, they would look at the false postive and false negatives rate and if too high, clearly the value of the machine would come into question and I strongly doubt the aura would have been approved. Health Canada approval is good enough for Europe once the CE rating has been achieved -- and it has been. In terms of the tips, I am trying to get clarification on that. But I am quite certain the tips are disposable, so there should be no cross-patient issues i.e., the same tip being used on different patients. Bottom line -- this is a big improvement over anything available right now that I am aware of. Hope that is some help.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next